CTC Ebbepark

Clinical Trial Consultants

Erectile Dysfunction

Dicot

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The goal of this clinical trial is to learn if the drug LIB-01 works to treat erectile dysfunction in male adults. It will also learn about the safety of the drug LIB-01. The main questions it aims to answer are:

* Does the drug LIB-01 improve erectile function in males with erectile dysfunction?
* What medical problems do participants have when taking the drug LIB-01? Researchers will compare the drug LIB-01 to a placebo (a look-alike substance that contains no drug) to see if the drug LIB-01 works to treat erectile dysfunction.

Participants will:

* Take the drug LIB-01 or a placebo every day for 3 days
* Visit the clinic every week for 4 weeks, and at 8 weeks, for checkups and tests

Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction

Clinical Trial Consultants | CTC Ebbepark

Site insights

Work at this site?

Active trials

Phase 2a Trial to Investigate the Efficacy of LIB-01 in Treatment of Erectile Dysfunction

Trial sponsors